Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects

This article reviews the in vitro and clinical trial data for the potential use of the potentiator, ivacaftor, and the corrector, lumacaftor, in patients with CF.

Source: Therapeutic Advances in Respiratory Disease - November 15, 2015 Category: Respiratory Medicine Authors: Kuk, K., Taylor-Cousar, J. L. Tags: Reviews Source Type: research